Key Highlights
- Revenue rose 124% year over year and 68% sequentially to a record USD 89 million.
- Backlog reached USD 742 million, up 293% year over year, including USD 347 million added through the Astrobotic acquisition.
- Bookings were a record USD 116 million, up 135% year over year, for a book-to-bill ratio of 1.3 times.
- The net loss attributable to the company was USD 55.7 million, and gross Margin was 11.5% versus 15.4%.
Quarter in Numbers
Voyager Technologies, Inc. (NYSE:VOYG), a space and defense technology company, reported third-quarter 2026 net sales of USD 89 million, up 124% year over year and 68% from the second quarter. For the nine months, net sales were USD 177 million, up 48%, reflecting Demand for defense and national security solutions and recent acquisitions, partly offset by the wind-down of lower-margin space service contracts.
Gross profit rose to USD 10.2 million from USD 6.1 million, but gross margin fell to 11.5% from 15.4% on investments in Manufacturing capacity and strategic programs. Sequentially, gross margin improved by 310 basis points on Operating Leverage from higher revenue. The net loss attributable to the company was USD 55.7 million, or USD 0.91 per share, and the non-GAAP adjusted loss was USD 52.8 million, or USD 0.87 per share. Adjusted EBITDA was a loss of USD 44.9 million, which the company tied to technology investment, expanded operational capability and integration of acquired businesses.
Bookings and Backlog
Bookings of USD 116 million were the strongest in company history, versus USD 49 million a year earlier, and trailing twelve month bookings were USD 329 million. Backlog was USD 742 million, compared with USD 336 million at June 30, 2026 and USD 266 million at December 31, 2025. The Astrobotic Acquisition contributed USD 347 million, including a USD 298 million NASA award that expands the lunar backlog. By our calculation, backlog of USD 742 million is about 8.3 times the quarter's revenue.
Business highlights included a strategic Partnership with Anduril, a multi-million dollar contract for an agentic artificial intelligence spectrum operations platform, completed acceptance testing for the Griffin-1 lunar lander ahead of a late-2026 launch, and several contracts to manage biopharmaceutical research missions on the International Space Station.
Starlab and Innovation Spend
The Starlab commercial space station program had achieved 39 milestones and USD 212.5 million of cumulative milestone cash receipts by September 30, including USD 1.5 million in the quarter. Signed commercial reservations rose to about USD 700 million from about USD 500 million last quarter. NASA released its Commercial LEO Destination Phase 2 request for proposals in early October, with submissions due in December 2026 and an award anticipated in spring 2027.
Innovation spend, including customer-funded development, was 36.9% of net sales excluding Starlab and 49.3% on a consolidated basis. Chairman and chief executive Dylan Taylor said record revenue, bookings and backlog came from accelerating demand and execution, and that the backlog gives multi-year Revenue visibility.
Liquidity and Guidance Markers
Total Liquidity was USD 815.7 million, including USD 553.6 million of cash and USD 262.1 million of available revolver capacity, against USD 841.1 million of convertible notes, net. The company raised the lower end of its full-year 2026 revenue guidance by USD 10 million to USD 285 million to USD 305 million, implying growth of about 72% to 84%. The fourth-quarter implied revenue, by our calculation, is USD 108 million to USD 128 million, compared with USD 89 million in the third quarter.
Items to track include gross margin as revenue scales, conversion of backlog into revenue, the pace of operating losses relative to liquidity, and the NASA decision timeline for commercial space stations.






Please wait processing your request...